Skip to main content

Halo Genomics and Life Tech Sign Co-Marketing Agreement

Premium

This story was originally published on April 7.

Halo Genomics has signed an agreement with Life Technologies to co-market its target enrichment kits with Life Tech's SOLiD system, the company said this week.

According to Halo, its products "fit well" with the Library Building benchtop device for automated library preparation for the SOLiD that Life Tech plans to launch soon.

"Halo Genomics' technology provides superior specificity and uniform coverage," Mark Gardner, vice president of Life Technologies, said in a statement.

Based in Uppsala, Sweden, Halo Genomics offers target enrichment kits and services for next-gen sequencing, based on its Selector technology (IS 3/1/2011).

Last month, the firm launched the HaloPlex PCR Reagent Kit, which allows users to amplify up to 2,000 exons in a single tube and includes library preparation for next-gen sequencing.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.